Abstract
Background
Patients with undifferentiated carcinoma of the esophagus (UEC) are rare and have a poor prognosis compared with those with differentiated squamous cell carcinomas (DECs). We compared clinicopathological and biological features of UEC and DEC, with emphasis on markers for epithelial cell origin, proliferation, and cell-cell adhesion.
Methods
Seven patients with UEC were compared with 21 with DEC. Immunohistochemical studies were performed by using monoclonal antibodies to cytokeratin, epithelial membrane antigen, p53, p21WAF1/CIP1, Ki-67, E-cadherin, desmoglein-1, and thrombomodulin.
Results
Patients with UEC had a poorer prognosis because of hematogenous metastasis at the time of presentation (mean survival, 6.5±6.2 vs. 35.5±28.9 months;P<.05). Immunohistochemical findings for cytokeratin and epithelial membrane antigen suggest that some UECs had epithelial origins. The following immunohistochemical profile of UEC was consistent with its highly malignant properties: (1) reduced or negative expression of cell-cell adhesion molecules such as E-cadherin, desmoglein-1, and thrombomodulin, (2) high positive rate for p53 and Ki-67, and (3) negative expression of p21WAF1/CIP1.
Conclusions
The immunohistochemical findings for UEC showed its high cell-proliferative activity and a high potential for metastasis. Clinical features of UEC were supported by the results of immunohistochemical findings.
Similar content being viewed by others
References
Thomas P, Battifora H. Keratins versus epithelial membrane antigen in tumor diagnosis: an immunohistochemical comparison of five monoclonal antibodies.Hum Pathol 1987:18:728–34.
Marshall CJ. Tumor suppressor gene.Cell 1991;254:313–26.
Vogelstein B, Kinzler KW. p53 function and dysfunction.Cell 1992;70:523–6.
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K. p53 mutations in human cancer.Science 1991;253:49–53.
Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mmd-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.Cell 1992;69:1237–45.
Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.Int J Cancer 1983;31:13–20.
Lam KY, Law SY, So MK, Fok M, Ma LT, Wong J. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous carcinoma.Cancer 1996;77:7–13.
Chino O, Makuuchi H, Shimada H, Machimura T, Mitomi T, Osamura RY. Assessment of the proliferative activity of superficial esophageal carcinoma using MIB-1 immunostaining for the Ki-67 antigen.J Surg Oncol 1998;67:18–24.
El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression.Cell 1993;75:817–25.
Shiozaki H, Oka H, Inoue M, Tamura S, Monden M. E-Cadherin mediated adhesion system in cancer cells.Cancer 1996;77:1605–13.
Natsugoe S, Aikou T, Shimada M, et al. Expression of desmoglein 1 in squamous cell carcinoma of the esophagus.J Surg Oncol 1994;57:105–10.
Maruyama I, Bell CE, Majerus PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.J Cell Biol 1985;101:363–71.
Tezuka Y, Yonezawa S, Maruyama I, et al. Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis.Cancer Res 1995;55:4196–200.
McKeown F. Oat-cell carcinoma of the esophagus.J Pathol Bacteriol 1952;64:889–91.
McCullen M, Vyas SK, Winwood PJ, Loehry CA, Parham DM, Hamblin T. Long-term survival associated with metastatic small cell carcinoma of the esophagus treated by chemotherapy, autologous bone marrow transplantation, and adjuvant radiation therapy.Cancer 1994;73:1–4.
Basher MA, Hulya L, Hwajalee R. Small cell carcinoma of the esophagus: report of three cases and review of the literature.Dig Dis Sci 1990;35:145–52.
Simon Ying-Kit L, Manson F, King-Yin L. Small cell carcinoma of the esophagus.Cancer 1994;73:2894–9.
Isolauri J, Mattila J, Kallioniemi OP. Primary undifferentiated small cell carcinoma of the esophagus: clinicopathological and flow cytometric evaluation of eight cases.J Surg Oncol 1991;46: 174–7.
Kevin LB, John BM, Alberto AD. Primary small cell carcinoma of the esophagus.J Clin Gastroenterol 1991;13:135–41.
Tateishi R, Taniguchi H, Horai T, Iwanaga T, Taniguchi H. Argyrophil cell carcinoma (apudoma) of the esophagus: a histopathologic entity.Virchows Arch A Pathol Anat Histopathol 1976;371:283–94.
Mori M, Matsukuma A, Adachi Y, et al. Small cell carcinoma of the esophagus.Cancer 1989;63:564–73.
Nishimaki T, Suzuki T, Nakagawa S, Watanabe K, Aizawa K, Hatakeyama K. Tumor spread and outcome of treatment in primary esophageal small cell carcinoma.J Surg Oncol 1997;64:130–4.
Tateishi R, Taniguchi H, Wada A, Horai T, Taniguchi K. Argyrophil cells and melanocytes in esophageal mucosa.Arch Pathol 1974;98:87–9.
Ho KJ, Herrera GA, Jones JM, Alexander CB. Small cell carcinoma of the esophagus: evidence for a unified histogenesis.Hum Pathol 1984;15:460–8.
Hollstein C, Metcalf RA, Welsh JA, Montesano R, Harris CC. Frequent mutation of thep53 gene in human esophageal cancer.Proc Natl Acad Sci USA 1990;87:9958–61.
Imazeki F, Omata M, Nose H, Ohto M, Isono K.p53 gene mutations in gastric and esophageal cancers.Gastroenterology 1992;103:892–6.
Coggi G, Bosari S, Roncalli M, et al. p53 protein accumulation and p53 gene mutation in esophageal carcinoma: a molecular and immunohistochemical study with clinicopathologic correlations.Cancer 1997;79:425–32.
Parenti AR, Rugge M, Frizzera E, et al. p53 overexpression in the multistep process of esophageal carcinogenesis.Am J Surg Pathol 1995;19:1418–22.
Cooper K, Taylor L. p53 protein expression and integrated HPV DNA are not mutually exclusive in esophageal cancer.Cell Vision 1995;2:49–51.
Nakamura T, Ide H, Eguchi R, et al. Expression of p53 protein related to human papilloma virus and DNA ploidy in superficial esophageal carcinoma.Surg Today 1995;25:591–7.
Baron PL, Gates CE, Reed CE, et al. p53 overexpression in squamous cell carcinoma of the esophagus.Ann Surg Oncol 1997; 4:37–45.
Goukon Y, Sasano H, Nishihira T, Mori S, Nagura H. p53 immunolocalization in cytology specimens: a study in human esophageal carcinoma.Diagn Cytopathol 1994;11:113–8.
Shimaya K, Shiozaki H, Inoue M, et al. Significance of p53 expression as a prognostic factor in esophageal squamous cell carcinoma.Virchows Arch A Pathol Anat Histopathol 1993;422: 271–6.
Sugimachi K, Kitamura K, Matsuda H, Mori M, Kuwano H, Ide H. Proposed new criteria for early carcinoma of the esophagus.Surg Gynecol Obstet 1991;173:303–8.
Yoshinaka H, Shimazu H, Fukumoto T, Baba M. Superficial esophageal carcinoma: a clinicopathological review of 59 cases.Am J Gastroenterol 1991;86:1413–8.
Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE. p53 protein expression in squamous cell carcinoma.Cancer 1994;74:2218–23.
Wang DY, Xiang YY, Tanaka M, et al. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China, and its relationship to progression and prognosis.Cancer 1994;74:3089–96.
Monges GM, Seitz JF, Giovannini MF, Gouvernet JM, Torrente MA, Hassoun JA. Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus.Cancer Detect Prev 1996;20:63–7.
Chanvitan A, Nekarda H, Casson AG. Prognostic value of DNA index, S-shape fraction and p53 protein accumulation after surgical resection of esophageal squamous cell carcinoma in Thailand.Int J Cancer 1995;63:381–6.
Takubo K, Nakamura K, Sawabe M, et al. Primary undifferentiated small cell carcinoma of the esophagus.Hum Pathol 1999;30:216–21.
Okudela K, Ito T, Kameda Y, Nakamura N, Kitamura H. Immunohistochemical analysis for cell proliferation-related protein expression in small cell carcinoma of the esophagus: a comparative study with small cell carcinoma of the lung and squamous cell carcinoma of the esophagus.Histol Histopathol 1999;14:479–85.
Doki Y, Shiozaki H, Tahara H, et al. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line.Cancer Res 1993;53:3421–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsumoto, M., Natsugoe, S., Nakashima, S. et al. Biological evaluation of undifferentiated carcinoma of the esophagus. Annals of Surgical Oncology 7, 204–209 (2000). https://doi.org/10.1007/BF02523655
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02523655